all-reports
Comprehensive Sustainability Reports
Q2 2025 Impact and Sustainability Update to investors
Comprehensive Sustainability Reports
all-reports
Comprehensive Sustainability Reports
Annual Report 2024 Corporate Governance
Comprehensive Sustainability Reports
all-reports
Thematic / Issue-specific Reports
Impact & Sustainability: Novartis 11th Annual ESG Investor Event
Thematic / Issue-specific Reports
all-reports
Comprehensive Sustainability Reports
Reporting Criteria for Novartis in Society Integrated Report 2024
Comprehensive Sustainability Reports
government-documents
Stakeholder Engagement & Transparency
Novartis in Society Integrated Report 2024
Stakeholder Engagement & Transparency
all-reports
Transparency & Accountability Reports
Report on Child Labor Due Diligence in Our Supply Chain 2024
Transparency & Accountability Reports
all-reports
Financial-linked Sustainability Reports
Sustainability-linked bond 2024 report
Financial-linked Sustainability Reports
all-reports
Transparency & Accountability Reports
Novartis SASB Index 2024
Transparency & Accountability Reports
all-reports
Comprehensive Sustainability Reports
Integrated Report 2024
Comprehensive Sustainability Reports
all-reports
Comprehensive Sustainability Reports
Q4 2024 Impact and Sustainability Update
Comprehensive Sustainability Reports
all-reports
Transparency & Accountability Reports
Transparency Act Statement 2024
Transparency & Accountability Reports
all-reports
Comprehensive Sustainability Reports
Novartis in Society Integrated Report 2023
Comprehensive Sustainability Reports
all-reports
Comprehensive Sustainability Reports
Integrated Report 2022
Comprehensive Sustainability Reports
all-reports
Financial-linked Sustainability Reports
Annual Report 2016
Financial-linked Sustainability Reports
first-reports
Financial-linked Sustainability Reports
Annual Report 2015
Financial-linked Sustainability Reports
first-reports
Financial-linked Sustainability Reports
Annual Report 2011
Financial-linked Sustainability Reports
first-reports
Financial-linked Sustainability Reports
Annual Report 2010
Financial-linked Sustainability Reports
first-reports
Financial-linked Sustainability Reports
Annual Report 2007
Financial-linked Sustainability Reports
first-reports
Financial-linked Sustainability Reports
Annual Report 2006
Financial-linked Sustainability Reports
first-reports
Financial-linked Sustainability Reports
Annual Report 2005
Financial-linked Sustainability Reports
first-reports
Financial-linked Sustainability Reports
Annual Report 2004
Financial-linked Sustainability Reports
government-documents
Human Rights & Social Responsibility
Novartis Position on Medicines for Patients with Rare Diseases
Human Rights & Social Responsibility
government-documents
Innovation, Technology & Responsible AI
ESG Index: Innovation
Innovation, Technology & Responsible AI
government-documents
Ethics & Integrity
Novartis Position on Falsified Medical Products
Ethics & Integrity
government-documents
Human Rights & Social Responsibility
Novartis Position on Responsible Clinical Trials
Human Rights & Social Responsibility
government-documents
Human Rights & Social Responsibility
Novartis Commitment to Diversity in Clinical Trials
Human Rights & Social Responsibility
government-documents
Ethics & Integrity
Novartis Position on Animal Research
Ethics & Integrity
government-documents
Innovation, Technology & Responsible AI
Novartis Position on innovative Biologic Medicines and Biosimilars
Innovation, Technology & Responsible AI
government-documents
Stakeholder Engagement & Transparency
Clinical Study Transparency: Clinical Study Registration, Results Reporting and Data Sharing
Stakeholder Engagement & Transparency
government-documents
Environment & Climate
Environmental Sustainability
Environment & Climate
government-documents
Human Rights & Social Responsibility
Human Rights Commitment Statement
Human Rights & Social Responsibility
government-documents
Innovation, Technology & Responsible AI
Novartis Position on innovative Biologic Medicines and Biosimilars
Innovation, Technology & Responsible AI
government-documents
Environment & Climate
Novartis Position on Pharmaceuticals in the Environment
Environment & Climate
government-documents
Governance & Compliance
Novartis Organizational Structure
Governance & Compliance
government-documents
Stakeholder Engagement & Transparency
Novartis Position on Collaborating with Patient Organizations
Stakeholder Engagement & Transparency
government-documents
Human Rights & Social Responsibility
ESG Index: Access to medicines
Human Rights & Social Responsibility
government-documents
Environment & Climate
Novartis Position on Pharmaceuticals in the Environment
Environment & Climate
government-documents
Sustainable Supply Chain
Environmental Sustainability Criteria for Suppliers
Sustainable Supply Chain
government-documents
Environment & Climate
Novartis Environmental Sustainability Strategy
Environment & Climate
government-documents
Ethics & Integrity
Our Code of Ethics
Ethics & Integrity
government-documents
Human Rights & Social Responsibility
Human Rights Commitment Statement
Human Rights & Social Responsibility
all-reports
Transparency & Accountability Reports
Modern Slavery Statement 2024 - Australia, Canada, and United Kingdom
Transparency & Accountability Reports
